SODa-BIC on Instagram
A more visual summary of the trial and relevant context (just 6 images to look at!). Infographics by Daniel Ramirez and Urvashi Khan
Day 3 : yet another IgA trial, and we are back with some flozin news: in ADPKD, their effect on hemoglobin, and on BP (with finerenone)
Day 2 was less exciting: we cover 1 IgA trial (Ravulizumab) along with another calcimimetic, and a pentoxifylline meta-analysis.
Day of Kidney Week 2026. The NephJC crew discusses 6 studies, including some blockbustr IgA news.
This week, we will discuss whether decreased donor transplantation improves mortality in all patients. In this target trial emulation standard donor, extended donor, donation after brain death and donation after cardiac death outcomes are compared across age groups with different co-morbid conditions.
A more visual summary of the trial and relevant context (just 6 images to look at!). Infographics by Daniel Ramirez and Urvashi Khan
El bicarbonato quizá no beneficie a todos los pacientes con acidosis metabólica. Tras SODa-BIC, la pregunta ya no es si funciona, sino ¿en qué pacientes podría seguir aportando beneficio?
Revisa el resumen visual creado por Daniel Ramirez #NephJC
Bicarbonate may not benefit all patients with metabolic acidosis. After SODa-BIC, the question is no longer whether it works, but which patients, might still benefit.
Check out the VA by Daniel Ramirez #NephJC
Does bicarbonate retard the progression of kidney allograft failure? check out the visual Abstract by Nyi Min Han